Elizabeth J. Shpall, MD, professor, deputy department chair, Department of Stem Cell Transplantation, Division of Cancer Medicine, medical director, Cell Therapy Laboratory, director, Cord Blood Bank, the University of Texas MD Anderson Cancer Center, discusses idelalisib and ibrutinib for the treatment of patients with chronic lymphocytic leukemia (CLL).
- See more at: onclive.com/onclive-tv/dr-s...
Jeff
The Use of Novel PI3K Inhibitors in CLL - Dr Jennifer Brown MD Dana-Farber Cancer Institute
Dr. Kanti Rai on the Future of CLL TherapyASH 2014. Dr. Sharman discusses the biology of our CLL cells
BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD
